Su Wang, MD MPH is an internal medicine physician and Medical Director of the Center for Asian Health at Saint Barnabas Medical Center in New Jersey, USA. She is living with hepatitis B and is President-Elect of the World Hepatitis Alliance, a patient led global organization whose mission is to harness the power of people living with hepatitis to achieve its elimination. She is a leader of the NOhep Medical Visionary program and an advocate of primary-care based HBV/HCV care and innovative screening strategies to reach at-risk populations.

Stuart Loveday is the CEO of Hepatitis NSW, Australia's first community based organisation and health promotion charity working for and on behalf of people with viral hepatitis. He is a former President and was a founding Board of Hepatitis Australia. Having worked in the hepatitis sector for almost 25 years, Stuart will be stepping down from his role in October 2019.

Alex Thompson is Professor-Director of Gastroenterology at St. Vincent’s Hospital Melbourne (University of Melbourne) Director of State-wide Prison Hepatitis Program in Victorian prisons. His research interests include models of care for hepatitis with a focus on elimination and the identification of host and viral determinants of the natural history and treatment outcomes of hepatitis B and C viruses. Alex was involved in the discovery of IL28B polymorphism as a predictor of treatment outcome in HCV. He has published widely in journals including Nature, Gastroenterology, Hepatology, Gut and Journal of Hepatology.

Joanne Bryant is an Associate Professor at the Centre for Social Research in Health in the Faculty of Arts and Social Sciences at UNSW. She is a social scientist trained in sociology and epidemiology, and has led a range of research projects focusing on harm reduction, hepatitis C, substance use and sexual health.